Form D · Biotechnology
RADIORX, INC.
Mountain View, CA · CIK 0001217984
Offering snapshot reported Apr 17, 2013 · SEC filing
- Reported sold
- $20.5M Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 14, 2008 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$16,490,011 → $20,450,011
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 17, 2013 | Amendment | $20,450,011 | $3,960,000vs Feb 29, 2012 | 4 | SEC filing |
| Feb 29, 2012 | Amendment | $16,490,011 | $5,768,000vs Feb 28, 2011 | 4 | SEC filing |
| Feb 28, 2011 | Amendment | $10,722,011 | No comparison | 3 | SEC filing |
| Mar 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-52568
Source: Form D, filed Apr 17, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Davis | Executive |
| Arnold L. Oronsky | Director |
| John T. Santini | Director, Executive |
| Gordon M. Saul | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
800 W El Camino Real Suite 180
Mountain View, CA, 94041
Mountain View, CA, 94041